Cormorant Private Healthcare Fund III LP, 10% Owner at Immuneering Corp (IMRX), sold 400,000 shares at $2.90 ($1.2M) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Open-market sale of $1.2M IMRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.90 | 398,600 | $1.2M | 99.6% |
| 2 | $2.97 | 280 | $832 | 0.1% |
| 3 | $2.98 | 10 | $30 | 0.0% |
| 4 | $3.01 | 10 | $30 | 0.0% |
| 5 | $3.03 | 600 | $2K | 0.2% |
| 6 | $3.05 | 100 |
| $305 |
| 0.0% |
| 7 | $3.07 | 100 | $307 | 0.0% |
| 8 | $3.07 | 300 | $921 | 0.1% |
| Total | $2.90 avg | 400,000 | $1.2M | 100% |
| Filing → |
| AMAM | BUY | 2023-03-16 | $10.2M | — | Filing → |